- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02866357
Respiratory Pathogens of Patients With Asthma and COPD Exacerbations
Multiplex Molecular Detection of Respiratory Pathogens of Adult Patients Admitted to Hospital for Exacerbation of Asthma and Chronic Obstructive Pulmonary Disease and Their Clinical Outcomes.
To assess the infective etiologies by quantitative polymerase chain reaction (qPCR) of acute exacerbation of COPD and asthma who required hospitalization.
To identify the HRV subtypes that are associated with COPD and asthmaexacerbations.
To assess if the infective aetiologies have associations with the clinical outcome of the patients.
Studieoversigt
Detaljeret beskrivelse
Objective: Chronic obstructive pulmonary disease (COPD) and asthma exacerbations both contribute to significant health care burden. Viral infections are important cause of acute exacerbation of COPD and asthma.
Hypothesis to be tested: 1. Assess infective etiologies by Multiplex Molecular Detection of nasopharyngeal aspirate (NPA) of patients with acute exacerbation of COPD and asthma; 2. Identify the human rhinovirus (HRV) (the commonest virus causing exacerbations) subtypes involved; 3.Assess if the infective etiologies have associations with clinical outcome of the patients.
Design and subjects: Prospective observational study. Patients admitted to hospital for acute exacerbation of COPD and asthma. Stable COPD and asthma patients will be recruited as controls.
Study instruments: Multiplex Molecular Detection of respiratory pathogens from NPA. Clinical data of the patient will be collected and spirometry will be performed.
Interventions: NPA collection from subjects. Main outcome measures: Primary aim is assessment of the prevalence of different viruses in relation to acute exacerbation of asthma and COPD. Secondary aim is to assess if a certain pathogen is associated with clinical outcomes including duration of hospitalization and 30 and 60 day readmissions and mortality Data analysis: Data will be analyzed by the Statistical Package of the Social Science Statistical software for Window, Version 22 (IBM SPSS Inc, IL, USA). Statistical methods including chi-square test, student t test and ANOVA will be used as appropriate.
Expected results: Understanding the epidemiology of respiratory viruses in COPD and asthma exacerbations allows further investigations of treatment options and gives information about the prognosis.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
-
Shatin, Hong Kong
- Prince of Wales Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
For COPD patients, patients who are admitted to the Prince of Wales Hospital with AECOPD will be screened for this study. AECOPD is defined when a patient with background COPD (with lung function parameters of FEV1/FVC ratio <70%)24 presented with at least two of the following major symptoms (increased dyspnoea, increased sputum purulence, increased sputum volume) or one major and one minor symptom (nasal discharge/congestion, wheeze, sore throat, cough) for at least two consecutive days.25,26
Inclusion criteria:
- Patients who has background COPD as mentioned above fulfilling the exacerbation criteria
- Age ≥40 years
For asthma patients, patients who are admitted to the Prince of Wales Hospital with asthma exacerbation will be screened for this study. Acute exacerbation of asthma is defined when an asthma patient presents with increasing dyspnea, wheeze or cough.
Inclusion criteria:
- Patients who has background asthma (defined as those with a consistent history and prior documented evidence of variable airflow obstruction, with evidence of an increase in FEV1 greater than 12% or 400 mL following bronchodilator or bronchial hyperresponsiveness on bronchial provocation testing, when stable)6 with any of the above exacerbation criteria for at least 2 consecutive days.
- Age ≥18 years
Control asthma and COPD subjects will be recruited from the respiratory clinic of the Prince of Wales Hospital. Subjects will be matched for age, sex and lung function of the COPD and asthma subjects. All recruited COPD subjects should have FEV1/FVC ratio of <70%. For asthma patients, they should have a clinical diagnosis of asthma (defined as those with a consistent history and prior documented evidence of variable airflow obstruction, with evidence of an increase in FEV1 greater than 12% or 400 mL following bronchodilator or bronchial hyperresponsiveness on bronchial provocation testing, when stable). These subjects should have no exacerbation of asthma or COPD 6 weeks prior to the assessment.
Exclusion Criteria:
Exclusion criteria for all patients:
- History of lung resection or other significant pulmonary disease like pulmonary fibrosis.
- Active infection like pulmonary tuberculosis
- Unable to complete assessment due to physical and/or cognitive impairment
- Having short life expectancy like subjects with terminal malignancy or intractable heart failure.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Prevalence of different types of viruses
Tidsramme: 1 month
|
Prevalence of different types of viruses
|
1 month
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Clincial outcomes
Tidsramme: 60 days
|
The secondary aim is to assess if a certain pathogen has association with clinical outcomes including duration of hospitalization and 30 and 60 day readmissions and mortality.
|
60 days
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Studiestol: David S Hui, MD, Chinese University of Hong Kong
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- COPD-asthma microb_v02
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med KOL
-
Baylor Research InstituteIkke rekrutterer endnu
-
Vastra Gotaland RegionRekruttering
-
Baystate Medical CenterNational Heart, Lung, and Blood Institute (NHLBI); University of Illinois... og andre samarbejdspartnereTrukket tilbage
-
Centre Hospitalier Intercommunal CreteilUniversity Hospital, Bordeaux; University Hospital, Caen; Centre Hospitalier... og andre samarbejdspartnereUkendt
-
Assiut UniversityIkke rekrutterer endnu
-
University of CalgaryAktiv, ikke rekrutterende
-
Marmara UniversityAfsluttet
-
University Hospital, BrestAfsluttet
-
VA Boston Healthcare SystemUkendt
-
Assiut UniversityIkke rekrutterer endnu
Kliniske forsøg med No intervention
-
Otsuka Pharmaceutical Factory, Inc.CelerionAfsluttet
-
Seoul National University HospitalSamsung Medical Center; Chosun University HospitalAfsluttetRadiofrekvensablation | Mikrobølge-ablationKorea, Republikken
-
University of MinnesotaAfsluttet
-
Swiss Federal Institute of TechnologyInstituto de Investigação em ImunologiaAfsluttetForstyrrelser i jernmetabolisme | Overbelastning af jern | PolyfenolerPortugal, Schweiz
-
Catharina Ziekenhuis EindhovenAfsluttet
-
Assistance Publique - Hôpitaux de ParisAfsluttetSeglcellesygdomFrankrig
-
China National Center for Cardiovascular DiseasesUkendt
-
Northwestern UniversityAfsluttet
-
University of Sao Paulo General HospitalUkendtParkinsons sygdomBrasilien